By Wendy Van Sickle
Columbus, Ohio, Aug. 20 – GS Finance Corp. priced $1.91 million of 0% underlier-linked notes due Aug. 22, 2022 linked to the S&P 500 index and the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by Goldman Sachs Group, Inc.
The notes will be called at par plus 15% if each asset closes at or above initial level on Aug. 16, 2021.
If the return of each underlier is zero or positive, the payout at maturity will be par plus 2 times the return of the lesser-performing asset.
If the return of each underlier is negative but greater than or equal to negative 10%, the payout will be par.
If either underlier falls by more than 10%, investors will be exposed to the decline of the lesser performer beyond 10%.
Goldman Sachs & Co. LLC is the underwriter.
| Issuer: | GS Finance Corp.
|
| Guarantor: | Goldman Sachs Group, Inc.
|
| Issue: | Autocallable underlier-linked notes
|
| Underlying assets: | S&P 500 index, SPDR S&P Biotech ETF
|
| Amount: | $1,905,000
|
| Maturity: | Aug. 22, 2022
|
| Coupon: | 0%
|
| Price: | Par
|
| Call: | At par plus 15% if each asset closes at or above initial level on Aug. 16, 2021
|
| Payout at maturity: | If the return of each underlier is zero or positive, par plus 2 times return of lesser-performing asset; if the return of each underlier is negative but greater than or equal to negative 10%, par; if either underlier falls by more than 10%, exposure to decline of the lesser performer beyond 10%
|
| Initial levels: | $110.20 for ETF, 3,372.85 for index
|
| Pricing date: | Aug. 14
|
| Settlement date: | Aug. 19
|
| Underwriter: | Goldman Sachs & Co. LLC
|
| Fees: | 2.675%
|
| Cusip: | 40057CNC1
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
